Product Details
Product Name:
Moxilubant |
CAS No.:
146978-48-5 |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | Moxilubant |
Description | Moxilubant is a small molecule leukotriene B4 receptor 1 (LTB4R) antagonist for the treatment of immune system disorders, skin and musculoskeletal disorders, and may be used in studies of psoriasis and rheumatoid arthritis. |
In vitro | Moxilubant inhibits LTB4 signaling with a potency of 2–4 nM.[1] |
In vivo | Moxilubant (100 to 500 mg; oral; once or twice daily for 7 days) inhibition LTB4 pathway reached at least 75% (150 mg) and pathway inhibition reached 100% (300 mg).[1] |
Storage | Shipping with blue ice. |
Inhibitors Related | Moxilubant HCl | Montelukast sodium | LTB4-IN-1 | Ontazolast | Linetastine | Croconazole | Montelukast | Bestatin | FPL 55712 | Tebufelone | LTβR-IN-1 | Ticolubant |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:2766566-11-2
$2785.00 / 50mg
-
CAS:2097604-91-4
$2500.00 / 100mg
-
CAS:534-46-3
$0.00 / 50mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$195.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |